Sommaire

Numéro précédent | Numéro suivant

• • ·Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction

    Page :813-818

    Stacy D. Fisher, Wojciech Zareba, Arthur J. Moss, Victor J. Marder, Charles E. Sparks, Judith Hochman, Chang-Seng Liang, Ronald J. Krone, for the THROMBO Investigators∗The THROMBO Investigators are listed in the . ∗ Appendix

    Résumé Résumé Plan Plan
• • ·Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients

    Page :819-824

    Yasuhiro Yokoyama, Bernard R Chaitman, Regina M Hardison, Ping Guo, Ronald Krone, Karen Stocke, Ihor Gussak, Michael J Attubato, Pentti M Rautaharju, George Sopko, Katherine M Detre

    Résumé Résumé Plan Plan  
• • ·Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease

    Page :825-829

    Andrew J Burger, Michael P Notarianni, Doron Aronson

    Résumé Résumé Plan Plan  
• • ·Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction

    Page :830-834

    Yochai Birnbaum, Galen S Wagner, Kathy B Gates, Trevor D Thompson, Gabriel I Barbash, Robert J Siegel, Christopher B Granger, Michael C Fishbein, Brian S Crenshaw, Robert M Califf

    Résumé Résumé Plan Plan  
• • ·Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings

    Page :835-839

    Elie Y Chakhtoura, Fayez E Shamoon, Jacob I Haft, George R Obiedzinski, Alice J Cohen, Rita M Watson

    Résumé Résumé Plan Plan  
• • ·Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia

    Page :840-845

    Masa-aki Kawashiri, Kouji Kajinami, Atsushi Nohara, Kunimasa Yagi, Akihiro Inazu, Junji Koizumi, Hiroshi Mabuchi

    Résumé Résumé Plan Plan  
• • ·Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM trial)

    Page :846-851

    Brian Olshansky, Vernon Hartz, Elizabeth Hahn, Jay Mason, M.Douglas Weaver, the ESVEM Investigators∗A list of the ESVEM Investigators appears in the . ∗ Appendix

    Résumé Résumé Plan Plan  
• • ·Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation

    Page :852-855

    Hiroshi Inoue, Hirotsugu Atarashi, for the Research Group for Antiarrhythmic Drug Therapy∗See for a list of investigators. ∗ Appendix

    Résumé Résumé Plan Plan  
• • ·Comparison of left ventricular outflow tract obstruction in interruption of the aortic arch and in coarctation of the aorta, with diagnostic, developmental, and surgical implications

    Page :856-862

    Jacqueline Kreutzer, Richard Van Praagh

    Résumé Résumé Plan Plan  
• • ·Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function

    Page :863-867

    Christopher M O’Connor, Wendy A Gattis, Linda Shaw, Michael S Cuffe, Robert M Califf

    Résumé Résumé Plan Plan  
• • ·Evolution of aortic dissection after surgical repair

    Page :868-872

    Rossella Fattori, Letizia Bacchi-Reggiani, Paola Bertaccini, Gabriella Napoli, Francesca Fusco, Massimo Longo, Angelo Pierangeli, Giampaolo Gavelli

    Résumé Résumé Plan Plan  
• • ·Effect of cisapride on QT interval in patients with end-stage renal disease

    Page :873-875

    Meri K Scott, Mia A Kim, Michael A Kraus, Bruce A Mueller, Ruchir A Sehra, Gregory T Altemose, Kevin M Sowinski

    
• • ·Implantable cardioverter defibrillator therapy for patients with life-threatening ventricular arrhythmias and severe heart failure

    Page :875-877

    Andrew Mecca, Tawfik Barakat, Hongsheng Guo, Brian Olshansky

    
• • ·Onset heart rate and microvolt t-wave alternans during atrial pacing

    Page :877-880

    Kaoru Tanno, Yoichi Kobayashi, Taro Adachi, Shynsyo Ryu, Taku Asano, Chiaki Obara, Takao Baba, Takashi Katagiri

     
• • ·Comparison of QT intervals in African-Americans versus Caucasians

    Page :880-882

    Elena B Sgarbossa, Sergio L Pinski, Deborah Williams, Biljana Pavlovic-Surjancev, Janice Tang, Richard G Trohman

     
• • ·Effects of systemic hypertension on arterial dynamics and left ventricular compliance in patients ≥70 years of age

    Page :882-886

    Alberto Pierini, Giovanni Bertinieri, Giovanni Pagnozzi, Michele Randazzo, Gabriella Gazzano, Simona Rossi, Guido Grassi, Giuseppe Mancia

     
• • ·Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure

    Page :886-889

    Sarah L Whorlow, Henry Krum

     
• • ·Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis

    Page :890-892

    James C Fang, Scott Kinlay, Paul Wexberg, Ali Amirzadeh, C.Michael Gibson, Andrew P Selwyn, Peter Ganz

     
• • ·Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women

    Page :892-895

    Arnon Blum, William H Schenke, Londa Hathaway, Rita Mincemoyer, Gyorgy Csako, Myron A Waclawiw, Richard O Cannon

     
• • ·Factor VIIa as a predictor of cardiac events following myocardial infarction in women

    Page :896

    Roger E Peverill